Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Biard

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Biometrical Journal. Biometrische Zeitschrift|November 3, 2021
DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment coursesMoreno Ursino, Lucie Biard, Sylvie Chevret
BMC Medical Research Methodology|May 28, 2026
Information borrowing in phase II randomized dose-ranging clinical trials in oncologyGuillaume Mulier, Vincent Lévy, Lucie Biard
Journal of Biopharmaceutical Statistics|July 27, 2023
Incorporating patient-reported outcomes in dose-finding clinical trials with continuous patient enrollmentAnaïs Andrillon, Lucie Biard, Shing M Lee
BMC Medical Research Methodology|December 15, 2022
Challenges of using external data in clinical trials- an illustration in patients with COVID-19Sylvie Chevret, Jean-François Timsit, Lucie Biard
Statistics in Medicine|July 2, 2021
Seamless phase I/II design for novel anticancer agents with competing disease progressionLucie Biard, Shing M Lee, Bin Cheng
BMC Medical Research Methodology|July 19, 2024
Bayesian sequential monitoring strategies for trials of digestive cancer therapeuticsGuillaume Mulier, Ruitao Lin, Thomas Aparicio, et al.
Scientific Reports|December 17, 2023
Comparison of models for stroke-free survival prediction in patients with CADASILHenri Chhoa, Hugues Chabriat, Sylvie Chevret, et al.
The Lancet. Oncology|July 9, 2022
Managing immune checkpoint inhibition in transplant recipientsCéleste Lebbé, Lucie Biard, Julie Delyon, et al.
Statistics in Biopharmaceutical Research|September 20, 2024
Bayesian Optimal Designs for Multi-Arm Multi-Stage Phase II Randomized Clinical Trials with Multiple EndpointsGuillaume Mulier, Sylvie Chevret, Ruitao Lin, et al.
Contemporary Clinical Trials Communications|January 29, 2021
Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trialsLucie Biard, Anne Bergeron, Vincent Lévy, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Biometrical Journal. Biometrische Zeitschrift|November 3, 2021
DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment coursesMoreno Ursino, Lucie Biard, Sylvie Chevret
BMC Medical Research Methodology|May 28, 2026
Information borrowing in phase II randomized dose-ranging clinical trials in oncologyGuillaume Mulier, Vincent Lévy, Lucie Biard
Journal of Biopharmaceutical Statistics|July 27, 2023
Incorporating patient-reported outcomes in dose-finding clinical trials with continuous patient enrollmentAnaïs Andrillon, Lucie Biard, Shing M Lee
BMC Medical Research Methodology|December 15, 2022
Challenges of using external data in clinical trials- an illustration in patients with COVID-19Sylvie Chevret, Jean-François Timsit, Lucie Biard
Statistics in Medicine|July 2, 2021
Seamless phase I/II design for novel anticancer agents with competing disease progressionLucie Biard, Shing M Lee, Bin Cheng
BMC Medical Research Methodology|July 19, 2024
Bayesian sequential monitoring strategies for trials of digestive cancer therapeuticsGuillaume Mulier, Ruitao Lin, Thomas Aparicio, et al.
Scientific Reports|December 17, 2023
Comparison of models for stroke-free survival prediction in patients with CADASILHenri Chhoa, Hugues Chabriat, Sylvie Chevret, et al.
The Lancet. Oncology|July 9, 2022
Managing immune checkpoint inhibition in transplant recipientsCéleste Lebbé, Lucie Biard, Julie Delyon, et al.
Statistics in Biopharmaceutical Research|September 20, 2024
Bayesian Optimal Designs for Multi-Arm Multi-Stage Phase II Randomized Clinical Trials with Multiple EndpointsGuillaume Mulier, Sylvie Chevret, Ruitao Lin, et al.
Contemporary Clinical Trials Communications|January 29, 2021
Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trialsLucie Biard, Anne Bergeron, Vincent Lévy, et al.
Pageof 10